BNP Paribas Financial Markets
KDNY

BNP Paribas Financial Markets’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

BNP Paribas Financial Markets’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-591
Closed -$6.83K – 4317
2020
Q2 		$6.83K Sell
591
-3,722
-86% -$51.3K ﹤0.01% 3878
2020
Q1 		$59.1K Buy
4,313
+2,356
+120% +$27.9K ﹤0.01% 3462
2019
Q4 		$11.5K Sell
1,957
-165
-8% -$897 ﹤0.01% 4113
2019
Q3 		$11.2K Buy
2,122
+648
+44% +$4.3K ﹤0.01% 4132
2019
Q2 		$11.3K Sell
1,474
-1,252
-46% -$19.1K ﹤0.01% 4077
2019
Q1 		$54.3K Buy
2,726
+2,600
+2,063% +$45.3K ﹤0.01% 3454
2018
Q4 		$1.67K Sell
126
-509
-80% -$10.2K ﹤0.01% 3829
2018
Q3 		$23.3K Buy
635
+56
+10% +$1.8K ﹤0.01% 3349
2018
Q2 		$20.3K Sell
579
-1,354
-70% -$51.9K ﹤0.01% 3494
2018
Q1 		$89.9K Buy
1,933
+21
+1% +$769 ﹤0.01% 3241
2017
Q4 		$71.7K Buy
1,912
+747
+64% +$32.6K ﹤0.01% 3475
2017
Q3 		$62K Buy
1,165
+263
+29% +$15.6K ﹤0.01% 3035
2017
Q2 		$51.4K Buy
902
+811
+891% +$40.7K ﹤0.01% 3179
2017
Q1 		$4.9K Sell
91
-399
-81% -$22.5K ﹤0.01% 3314
2016
Q4 		$27.9K Sell
490
-87
-15% -$5.26K ﹤0.01% 3062
2016
Q3 		$35.9K Buy
577
+311
+117% +$22K ﹤0.01% 2582
2016
Q2 		$15.1K Buy
+266
New +$16.2K ﹤0.01% 2715
2016
Q1 		– Sell
-566
Closed -$79.7K – 3177
2015
Q4 		$79.7K Buy
566
+158
+39% +$21.5K ﹤0.01% 2485
2015
Q3 		$39.6K Buy
+408
New +$48.6K ﹤0.01% 3028

Other funds holding KDNY

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

BNP Paribas Financial Markets's KDNY Position: Q3 2020 in Review

BNP Paribas Financial Markets sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2020, closing a stake of 591 shares — an estimated $6.83K sold.

BNP Paribas Financial Markets first reported a position in KDNY in Q3 2015 and held it in 19 quarters. The position peaked at $89.9K in Q1 2018. 70 funds tracked by Wall St. Rank hold KDNY as of Q3 2020.

  • BNP Paribas Financial Markets reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 591 Chinook Therapeutics, Inc. Common Stock shares in Q3 2020, an estimated $6.83K.
  • BNP Paribas Financial Markets first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2015 and held it in 19 quarters.
  • BNP Paribas Financial Markets's Chinook Therapeutics, Inc. Common Stock position peaked at $89.9K in Q1 2018.
  • 70 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2020, filed 30 Oct 2020.